Canadian CANNAINVESTOR Magazine March 2018 | Page 203

203

CCIM: Building off of the last two questions – Durham College is also located in Oshawa and Durham College (and UOIT) has a top nursing program. Are there any plans to integrate your partnership with Durham College and your partnership with the Oshawa Health Clinic?

EMC: Nurses play an incredibly important role in our education programs and our team of Educators continues to grow. Durham College has proven to be a great partner so far and has shown great commitment to advancing the dialogue on medical cannabis in Canada. We are eager to find more ways to work with them.

CCIM: Emblem has announced two significant changes to the Executive recently – Nick Dean as the CEO and Alex Stojanovic as CFO. What do these appointments bring to Emblem and therefore ultimately to shareholders?

EMC: The new appointments signify having the right individuals to pursue the next phase of growth and strategic opportunities for Emblem.

CCIM: The consolidation curve cannot be avoided for any industry and we have been witness to M&A activity in the cannabis space that kicked off with Canopy’s acquisition of Mettrum. To the extent that you can answer, does EMC have any plans to expand through M&A?

EMC: We are always exploring strategic growth opportunities. However, we take a more disciplined approach on valuation when looking at opportunities that others might. We prefer to avoid “buy now, worry about it later”. M&A is certainly part of our strategy.

CCIM: Even with the December financials, your sales of oils will not show (revenue) until 2018 Q1 and that means it could be May or even June before we start to see those numbers in your published financial statements … can you give our readers any revenue numbers for oils and revenue and patient growth in general?

EMC: We are not in a position to share specific numbers, but we are very pleased with the initial response to our oils launch.